Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Heald

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Archives of Dermatology|June 17, 2009
Primary cutaneous T-cell lymphoma localized to the lower leg: a distinct, locally aggressive cutaneous T-cell lymphomaBrian Poligone, Lynn D Wilson, Antonio Subtil, et al.
Journal of the American Academy of Dermatology|October 9, 2007
Persistent agmination of lymphomatoid papulosis: an equivalent of limited plaque mycosis fungoides type of cutaneous T-cell lymphomaPeter Heald, Antonio Subtil, Deborah Breneman, et al.
International Journal of Dermatology|May 15, 2010
Facial discoid dermatosisChristine J Ko, Peter Heald, Richard J Antaya, et al.
The American Journal of Dermatopathology|January 22, 2009
A distinct entity in the spectrum of the CD30+ cutaneous lymphoproliferative diseases: oligolesional nodules with pseudoepitheliomatous hyperplasia followed by spontaneous resolutionMaya Zayour, Elaine Gilmore, Peter Heald, et al.
JAAD Case Reports|July 10, 2018
Treatment of generalized deep morphea and eosinophilic fasciitis with the Janus kinase inhibitor tofacitinibSa Rang Kim, Alexandra Charos, William Damsky, et al.
Journal of Cutaneous Pathology|July 16, 2003
Sezary syndrome: cutaneous immunoperoxidase double-labeling technique demonstrates CD4/CD8 ratio non-specificityErika M Balfour, Earl J Glusac, Peter Heald, et al.
Journal of the American Academy of Dermatology|October 25, 2003
Topical bexarotene therapy for patients with refractory or persistent early-stage cutaneous T-cell lymphoma: results of the phase III clinical trialPeter Heald, Marilyn Mehlmauer, Ann G Martin, et al.
JAAD Case Reports|January 11, 2021
Treatment of angiolupoid sarcoidosis with tofacitinib ointment 2% and pulsed dye laser therapyKatelyn Singh, Alice Wang, Peter Heald, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 8, 2025
Gammopathic dermopathies: A retrospective review of cutaneous response to haematologic therapyMica C G Williams, Shaman Bhullar, Brianna Olamiju, et al.
American Journal of Clinical Pathology|October 20, 2004
Flow cytometric DNA ploidy analysis of peripheral blood from patients with sezary syndrome: detection of aneuploid neoplastic T cells in the blood is associated with large cell transformation in tissueSa Wang, Ning Li, Peter Heald, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Archives of Dermatology|June 17, 2009
Primary cutaneous T-cell lymphoma localized to the lower leg: a distinct, locally aggressive cutaneous T-cell lymphomaBrian Poligone, Lynn D Wilson, Antonio Subtil, et al.
Journal of the American Academy of Dermatology|October 9, 2007
Persistent agmination of lymphomatoid papulosis: an equivalent of limited plaque mycosis fungoides type of cutaneous T-cell lymphomaPeter Heald, Antonio Subtil, Deborah Breneman, et al.
International Journal of Dermatology|May 15, 2010
Facial discoid dermatosisChristine J Ko, Peter Heald, Richard J Antaya, et al.
The American Journal of Dermatopathology|January 22, 2009
A distinct entity in the spectrum of the CD30+ cutaneous lymphoproliferative diseases: oligolesional nodules with pseudoepitheliomatous hyperplasia followed by spontaneous resolutionMaya Zayour, Elaine Gilmore, Peter Heald, et al.
JAAD Case Reports|July 10, 2018
Treatment of generalized deep morphea and eosinophilic fasciitis with the Janus kinase inhibitor tofacitinibSa Rang Kim, Alexandra Charos, William Damsky, et al.
Journal of Cutaneous Pathology|July 16, 2003
Sezary syndrome: cutaneous immunoperoxidase double-labeling technique demonstrates CD4/CD8 ratio non-specificityErika M Balfour, Earl J Glusac, Peter Heald, et al.
Journal of the American Academy of Dermatology|October 25, 2003
Topical bexarotene therapy for patients with refractory or persistent early-stage cutaneous T-cell lymphoma: results of the phase III clinical trialPeter Heald, Marilyn Mehlmauer, Ann G Martin, et al.
JAAD Case Reports|January 11, 2021
Treatment of angiolupoid sarcoidosis with tofacitinib ointment 2% and pulsed dye laser therapyKatelyn Singh, Alice Wang, Peter Heald, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 8, 2025
Gammopathic dermopathies: A retrospective review of cutaneous response to haematologic therapyMica C G Williams, Shaman Bhullar, Brianna Olamiju, et al.
American Journal of Clinical Pathology|October 20, 2004
Flow cytometric DNA ploidy analysis of peripheral blood from patients with sezary syndrome: detection of aneuploid neoplastic T cells in the blood is associated with large cell transformation in tissueSa Wang, Ning Li, Peter Heald, et al.
Pageof 3